Meeting in Annecy – see the social media story

Ethics and emerging epidemic infections

Ethics and emerging epidemic infections

Global Forum on Bioethics in Research meeting at Fondation Merieux, 3-4 November 2015

  1. Introductions to the meeting
  2. Research & bioethics in #emergingpathogen #epidemics. Look forward 2 attending Global Forum on Bioethics in Research Nov2-4 #gfbr2015
  3. Off to Annecy for #GFBR2015: two days of intense discussions on #bioethics and #globalhealth #research in a beautiful campus, stay tuned!
  4. Excited! #GFBR2015-Research ethics in epidemics. Thanks 4 your generosity @wellcometrust @gatesfoundation @NIH UK-MRC & Fondation Mérieux
  5. Greatful 2B @ #GFBR2015 in Annecy to discuss ’emerging epidemics+experimental tx’ ie: Ebola. ~50ppl, 35 countries. Will tweet if solved!
  6. I’m at #gfbr2015 mtg in Annecy on emerging epidemics and experimental treatments
  7. And #gfbr2015 begins with a welcome by Christophe Longuet from the Fondation Merieux- talks about the history of the wonderful host venue
  8. Tweeting from Global Forum on Bioethics in Research today. Christophe Longuet giving welcome remarks #GFBR2015 https://t.co/EDidIOCFSq

    Tweeting from Global Forum on Bioethics in Research today. Christophe Longuet giving welcome remarks #GFBR2015 pic.twitter.com/EDidIOCFSq
  9. Delighted to be here in Annecy for #gfbr2015 on Ethics of Emerging Epidemic Infections and Experimental Medical Treatments
  10. Now Florencia Luna, member,Interim Steering Committee of the Global Forum for #Bioethics in #Research talks about history of forum #gfbr2015
  11. GFBR-Platform for open & transparent discussions on ethics in international research-Florence Luna. #GFBR2015 discusses ethics and epidemics
  12. highlighted history of the Fondation Merieux & the work being done by them in infectious disease research #GFBR2015  https://twitter.com/BhadeliaMD/status/661447214611505152 
  13. Keynote address by Ross Upshur "Ethics & Epidemics: are lessons ever learned?"
  14. And a pleasure to have @upshur_ross presents the opening plenary at #gfbr2015 on Ethics and Epidemics: Are lessons ever learned
    #bioethics
  15. At #gfbr2015 talks about the disruption to communities caused by #pandemics and #epidemics– lessons learnt from past experiences #bioethics
  16. Ross Upshar @UofT keynote: Historical perspective on outbreaks & unique research challenges.”We are both victims & vector alike” #gfbr2015
  17. Issues around #stigma, #vulnerabilities & #frailty of the human condition in the context of epidemics raised by @upshur_ross
    #gfbr2015
  18. Ross talks abt ethics & epidemic modeling-apocalyptic models might raise awareness but do not often help
    #gfbr2015 #epidemics #globalhealth
  19. .@upshur_ross Need for ethics in mathematical modeling conversation. Reflections of models during Ebola epidemic #gfbr2015
  20. @upshur_ross gives Keynote lecture @ #GFBR2015. Ethics and Epidemics: Are lessons ever learned? “We are both victims and vectors”
  21. .@upshur_ross notes black market for Ebola survivor blood – expect the unexpected during outbreaks. #GFBR2015.
  22. Std research ethics norms & guidelines apply to research in epidemics but requires reflection & adaptation to context @upshur_ross #gfbr2015
  23. .@upshur_ross Ethx issues: Failure of due diligence re:residual samples/biobanking during Ebola! Monitored use vs. compasionate. #gfbr2015
  24. #gfbr2015. “Addressing ethical issues in epidemics is critical to survival of our species” @upshur_ross nuff said!
  25. Very stimulating keynote address by @upshur_ross at the #gfbr2015. Pertinent questions to be answered. Look forward to the discussions
  26. In epidemics such as EVD, there is need for open discussions on management of residual samples,sample ownership & IC @upshur_ross #gfbr2015
  27. Great opening keynote at #gfbr2015 from @upshur_ross of @UofT on Ebola outbreak ‘nothing new about the lessons learned’ @wellcometrust
  28. Session 1: Trust and Community Engagement
  29. . @AnantBhan opens case studies section on research ethics and "Trust & Community Engagement" #GFBR2015 https://t.co/HncwU9AOtw

    . @AnantBhan opens case studies section on research ethics and “Trust & Community Engagement” #GFBR2015 pic.twitter.com/HncwU9AOtw
  30. @AnantBhan opens case discussions on trust, community engagement and ethical issues around global health research and outbreaks #gfbr2015
  31. Emilie Venables shares experienced and Ethical challenges of anthropological research in Liberia during Ebola outbreak #gfbr2015
  32. Role of anthropologists in outbreaks: understanding cultural context, community acceptance of interventions, etc #gfbr2015
  33. #GFBR2015 MSF sent anthropoligists to inform health promotion during Ebola. Now hearing about ethics issues – fascinating!
  34. ERB approval in outbreaks: how quick is quick enough? #gfbr2015
  35. Emilie Venables @MSF_southafrica There was community interest in research during EVD outbreak. People wanted their voices heard #gfbr2015
  36. Consent in qualitative/anthropological research in outbreaks: Is oral consent enough? Does written consent deter participation? #gfbr2015
  37. Emilie Venables talking about community engagement during the Ebola response #gfbr2015
  38. #gfbr2015 incredibly impressed by wide representation from Northern & Southern hemisphere experts. Meaningful exchange 2 promising results!
  39. Emilie Venables @MSF makes case for having standardised research protocols for pre-approval before outbreak occurs #gfbr2015 @wellcometrust
  40. Stimulating 1st session of #gfbr2015 &qs flowing: if/how to expedite ethical review in epidemics? Do health interventions blur w/ research?
  41. #GFBR2015 Q 4 MSF – I get it, but how to justify $$ to anthropological research during Ebola to donors and affected communities?
  42. Emilie Venable @MSF_southafrica argues for some degree flexibility in REC review for anthropological studies during epidemics.#gfbr2015
  43. Should researchers from humanitarian organisations receive differential ethics reviews? #gfbr2015
  44. Community engagement in research: Maureen Njue shares experiences from KEMRI #gfbr2015
  45. #gfbr2015 Very informative presentation -Phase 1 Ebola Vaccine Trial in Kenya
  46. KEMRI engaged partners at National, county and individual levels for successful Phase I Ebola vaccine trial in Kenya #gfbr2015
  47. Stakeholders engaged by KEMRI wanted to know why Phase I EVD was being conducted in Kilifi, Kenya #gfbr2015
  48. @KEMRIW‘s Patricia Njuguma highlights importance of information and community engagement in research and trials during outbreaks #gfbr2015
  49. Patricia Njuguna, Maureen Njue @KEMRIW outline factors for success of their comm. engagement re Ebola vaccine trial #gfbr2015 @wellcometrust
  50. Maureen Njue @KEMRIW EVD Phase1 vaccine trial in Kenya #gfbr2015 Global solidarity in fight against epidemics despite geographical location
  51. Prof Godfrey Tangwa presenting rich and evocative practical ethical dilemmas for patients, families and health professionals #gfbr2015
  52. Godfrey Tangwa talks abt the dilemmas faced by transport staff in ambulances dealing with #Ebola #gfbr2015 #bioethics #Africa #healthcare
  53. @JennyferAmbe @get_africa using convalescent plasma in the fight against EVD. Indigenous response & African leadership #gfbr2015
  54. Jennyfer Ambe and Godfrey Tangwa present a case study on use of convalescent plasma during the EVD outbreak in Liberia #gfbr2015
  55. #GFBR2015 Africans doing community engagement in Africa – innovative vs. common sense. Ethics of recruiting EVD survivors – harrowing cases.
  56. Godfrey Tangwa, @JennyferAmbe introduce ethical dilemmas re using blood from Ebola survivors in research/treatment #gfbr2015 @wellcometrust
  57. Striking a balance between indigenous response, African leadership and non-African leadership in epidemics in Africa-Getnet Tadele #Gfbr2015
  58. #GFBR2015 Profound words Dr.Tangwa of UofYaounde “we need to be clear about epistemology of allopathic medicine” in all research.
  59. @synthymama @JennyferAmbe @Prf Tangwa way to go esteemed @get_africa members. So proud of you all for your good works #gfbr2015
  60. #GFBR2015 @get_africa first session of GFBR was on Trust and Community Engagement. Ethical questions to be discussed during the next 2 days.
  61. Pecha Kucha sessions – rapid 5 minute presentations from participants
  62. Great talk @BrowneKatharine incentives 4 research participants, finds $ not top, many altruistic + selfish motives #gfbr2015 @wellcometrust
  63. Something new tried out at #gfbr2015: short presentations by participants in the Pecha-kucha session
#bioethics https://t.co/IWIeCMajTw

    Something new tried out at #gfbr2015: short presentations by participants in the Pecha-kucha session
    #bioethics pic.twitter.com/IWIeCMajTw
  64. Interesting Pecha Kucha sessions at the #gfbr2015. 5mins presentations with 20secs per slide
  65. The other parallel session with Pecha Kucha sessions ongoing: small concise presentations back to back 
#gfbr2015 https://t.co/wIBNvKovLX

    The other parallel session with Pecha Kucha sessions ongoing: small concise presentations back to back
    #gfbr2015 pic.twitter.com/wIBNvKovLX
  66. Sofia Salas and the Mapuche protest-How far should samples travel and who owns the blood? #gfbr2015 Pecha Kucha session
  67. Great Pecha Kucha presentation by Prof Sofia Salas about ethics of cross-border transfer of human specimens in research #gfbr2015
  68. I discuss: How do you provide good care when standards of care are evolving in emerging path outbreaks? #gfbr2015 https://t.co/2e2ma7Z3yv

    I discuss: How do you provide good care when standards of care are evolving in emerging path outbreaks? #gfbr2015 pic.twitter.com/2e2ma7Z3yv
  69. There’s a need for better ways 4 medics + researchers to share dilemmas etc in field in outbreaks says @BhadeliaMD #gfbr2015 @wellcometrust
  70. Session 2: Trust and Inter-organisational Relationships
  71. Ama Edwin discusses public outcry/fear at start of EBOV vaccine trial in Ghana, challenges w media, politics, perceptions #gfbr2015
  72. Since using prelim data 2 make clinical choices,need exchange w researchers re data caveats,interpretation #gfbr2015  https://twitter.com/pjwoodgate/status/661534897698377729 
  73. Excellent discussion on history, role of state, cultural/social norms forming background of EBOV trials in Guinea from @alameenuy #gfbr2015
  74. @alameenuy for Morenike. importance of engaging communities in protocol design .@get_africa #gfbr2015
  75. Would a researcher facing death want to be treated or studied? #GFBR2015 Dr. Tangwa, UofYaonunde
  76. In Yaounde airport, scanners take your temperature from afar, but no running water in the bathrooms! – Dr. Tangwa UofYaounde #gfbr2015
  77. Godfrey Tangwa (Uni Yaounde): lessons Ebola outbreak not been learned, esp. re inadequate infrastructure/facilities #gfbr2015 @wellcometrust
  78. @AnantBhan @pjwoodgate @michaelethox Sorry to miss #gfbr2015. Many thanks for your tweets. Really great discussions. Best wishes
  79. We miss you @ptindana in #gfbr2015 your work referenced already here in the sessions! @pjwoodgate @michaelethox
  80. @ptindana we miss you #gfbr2015. Great discussions on community engagement and trust. Would have loved to get your perspective
  81. Peter Kilmarx @Fogarty_NIH emphasises need to avoid 2nd class level of review for investigative drug trials in vulnerable groups #gfbr2015
  82. Phillippe Calain (MSF) calls for socio-anthropological study of African AND NGO/relief communities re:beliefs & practices. #gfbr2015
  83. Communities in rural Africa are very intelligent and capable of making smart decisions and informed consent #gfbr2015
  84. Lessons from rVSV-vectored vaccine trial in Guinea: community engagement, trust, communication and respect are key #gfbr2015
  85. Great panel w/Ana-Maria Henao Restrepo, Peter Kilmarx, Godfrey Tangwa,Philippe Calain &chair @michaelethox #gfbr2015 https://t.co/qtreqhhPwn

    Great panel w/Ana-Maria Henao Restrepo, Peter Kilmarx, Godfrey Tangwa,Philippe Calain &chair @michaelethox #gfbr2015 pic.twitter.com/qtreqhhPwn
  86. As evening sets in Annecy, day 1 of #gfbr2015 ends with continuing group discussions on challenges in #research https://t.co/LQjLAfJXfR

    As evening sets in Annecy, day 1 of #gfbr2015 ends with continuing group discussions on challenges in #research pic.twitter.com/LQjLAfJXfR
  87. . @JennyferAmbe indeed, thanks to excellent presentations and discussions thanks to you and other colleagues #gfbr2015
  88. Day 2: Equity in Access to Treatment
  89. Ross Upshur yesterday. From the bird flu to swine flu and SARs epidemics, it seems little has been learnt for better response #gfbr2015
  90. Something wht we learn is that often not much has changed or been learnt frm past experiences @upshur_ross #gfbr2015  https://twitter.com/alameenuy/status/661815625153708032 
  91. #gfbr2015 Day 2 Barbara Sina and Katherine Littler giving feedback on outcomes of the group work session. https://t.co/yeppgXSIbc

    #gfbr2015 Day 2 Barbara Sina and Katherine Littler giving feedback on outcomes of the group work session. pic.twitter.com/yeppgXSIbc
  92. How to build trust before epidemics strike?. How are community engagements different in epidemic settings? #gfbr2015
  93. Voo Teck Chuan. Presentation on access to novel flu vaccines for those that contributed to seed stock for H5N1 virus samples. #gfbr2015
  94. Day 2 #gfbr2015 Voo Teck Chuan on flu vaccine dev, equity of access 4 LMICs who contribute 2 seed stock, #globalhealthsecurity
  95. Ethical issues around Sharing and using biological samples for timely development of vaccines and therapeutics in epidemics #gfbr2015
  96. Does biological samples include public health information? #gfbr2015
  97. Voo Teck Chuan discusses Benefit Sharing in H5N1 flu vaccine research in Indonesia. #gfbr2015
  98. Using lessons from H5N1, Dr Voo discusses Equity, access to vaccines and therapy, intellectual property rights, etc in epidemics #gfbr2015
  99. To what extent can states retain sovereignty over biological samples? Voo Teck Chuan @#gfbr2015
  100. With huge global disparities, how can we ensure equity and justice in research, epidemics and access to therapy? #gfbr2015 day 2 discussions
  101. Important issue raised at #gfbr2015: when we talk about data, sample, information sharing in #pandemics, is reciprocity or justice at heart?
  102. #gfbr2015 Day 2 first case: a real predencent for a new look at guidelines for biospecimen tranfer and benefit sharing.
  103. #gfbr2015 Breakout sessions: Access to therapy/vaccine following trials – participants vs population? At what cost? For how long?
  104. Great discussion re equity/fairness in access to experimental drugs in outbreaks vs managing risk of potential harm at same time #gfbr2015
  105. Jayakrishnan discussing Kayasanur Forest Disease (KFD), an emerging disease affecting Kerala, India #gfbr2015
  106. #KFD is tick borne, identified in 1957, has claimed more than 800 lives. No transmission to neighbouring countries #gfbr2015
  107. #KFD has no treatment, vaccine efficacy wuestionable. Recent outbreak in Kerala raised ethical questions #gfbr2015
  108. Where will the affected patients seek treatment – no govt facility within 3.5hrs of outbreak zone? Should the vaccine be used? #gfbr2015
  109. Is it ethical to vaccinate? Who to vaccinate first: forest worker or population? What data should be collected during vaccination? #gfbr2015
  110. Earlier in AM, equity in access to research data to developing countries as part of fairness during infectious diseases outbreaks #gfbr2015
  111. #KFD vaccination: An RCT will be ideal but not feasible mainly because of trust issues among affected population #gfbr2015
  112. Development of WHO ethics implementation guidance
  113. Abha Saxena @WHO: Policy makers and decision makers need a moral compass to make decisions during #epidemics #bioethics
    #gfbr2015
  114. Abha Saxena @WHO on why ethics are critical during epidemics-High mortality, scarcity of stuff, action in face of uncertainty #gfbr2015
  115. Abha Sanexa of @WHO discusses development of ethics guidelines in/for epidemics #gfbr2015
  116. #GFBR2015 People on the ground found it hard to use the guidelines. Guidance was lacking @synthymama @AnantBhan @BhadeliaMD @alameenuy
  117. Session 4: Adaptive Trial Design
  118. .@upshur_ross “Whereof one cannot speak,thereof one must be silent”Wittgenstein, need 4 data, adaptive trial design in outbreaks. #gfbr2015
  119. #gfbr2015  Nancy Kass. Ethics is not about which of two arguments is the better https://t.co/GTdtnqvCwy

    #gfbr2015 Nancy Kass. Ethics is not about which of two arguments is the better pic.twitter.com/GTdtnqvCwy
  120. Aissatou Touré @institutpasteur discusses ethical dilemma faced by EVD patients and validity of their consent to inv drug trials #GFBR2015
  121. Panel on adaptive design. Nancy Kass, researcb must not be about the researchers, rather about subjects  #gfbr2015 https://t.co/7N6dAlCJ9h

    Panel on adaptive design. Nancy Kass, researcb must not be about the researchers, rather about subjects #gfbr2015 pic.twitter.com/7N6dAlCJ9h
  122. Follow conversation at this week’s “Global Forum for #Bioethics in #Research” > #gfbr2015
  123. Summary, Conclusions & GFBR Award
  124. The wrap-up session for #gfbr2015 begins with Doug Wassenaar announcing the second GFBR award to Prof Solly Benatar UCT & @UofT #bioethics
  125. Prof Solomon Benatar receives global forum for bioethics research award on his outstanding achievements in bioethics #GFBR2015
  126. Global Forum in Bioethics Research 2015 Award goes to…Prof. Solly Benatar @UCTHealthSci @UCT_Research #gfbr2015. Congrats Prof. Benatar!
  127. GFBR – debate platform on ethical issues in int health research; stimulates conceptual/empirical research to inform policy #GFBR2015
  128. Our Nancy Kass w Fogarty African #Bioethics Trng Prog alums Robt Ssekubugu, Godfrey Tangwa & @alameenuy - #gfbr2015 https://t.co/wuozT0S3oI

    Our Nancy Kass w Fogarty African #Bioethics Trng Prog alums Robt Ssekubugu, Godfrey Tangwa & @alameenuy#gfbr2015 pic.twitter.com/wuozT0S3oI
  129. #gfbr2015. Last day of Meeting. A multicultural academic experience!
  130. #gfbr2015- all the lovely people who made it an engrossing two days of discussions. Thanks everyone!
https://t.co/uuZssZBgQF

    #gfbr2015– all the lovely people who made it an engrossing two days of discussions. Thanks everyone!
    pic.twitter.com/uuZssZBgQF
  131. 7 case studies, 16 pecha kuchas, 4 breakouts, 2 panels, 2 skypes, 1 award & lots of coffee later, #gfbr2015 draws to a close. Thank you all!
  132. If you want to follow up from #gfbr2015 inc. travel fellowships, presentations & meeting report, keep an eye on  http://www.gfbr.global 
  133. Post #gfbr2015 – I’m reminded that 11313 died in 2014-15 Ebola outbreak vs 16,500 who DIE EVERY DAY from smoking. Which is a PH emergency?